Review article: Management of ascites and associated complications in patients with cirrhosis
- PMID: 18081661
- DOI: 10.1111/j.1365-2036.2007.03482.x
Review article: Management of ascites and associated complications in patients with cirrhosis
Abstract
Background: Ascites is the most common complication of cirrhosis, associated with an expected survival below 50% after 5 years. Prognosis is particularly poor for patients with refractory ascites and for those developing complications, including spontaneous bacterial peritonitis (SBP) and hepatorenal syndrome (HRS).
Aim: To provide an evidence-based overview of the pathophysiology, diagnosis and clinical management of ascites secondary to liver cirrhosis.
Methods: Review based on relevant medical literature.
Results: Portal hypertension, splanchnic vasodilatation and renal sodium retention are fundamental in the pathophysiology of ascites formation. The SAAG (serum-ascites albumin gradient) allows reliable assessment of the cause of ascites. The majority of cirrhotic patients with ascites can be managed with dietary sodium restriction in combination with diuretic agents. Large volume paracentesis with albumin suppletion and TIPS are therapeutic options in patients with refractory ascites. Prophylactic antibiotics for SBP should be given in certain patient populations.
Conclusions: Recent advances in the diagnosis and treatment of ascites and associated complications have improved the medical management and poor prognosis of patients with these manifestations of advanced liver disease. Early diagnosis, adequate treatment and focus on prevention of complications remain essential as well as timely referral for liver transplantation.
Similar articles
-
Ascites and spontaneous bacterial peritonitis: an Asian perspective.J Gastroenterol Hepatol. 2009 Sep;24(9):1494-503. doi: 10.1111/j.1440-1746.2009.06020.x. J Gastroenterol Hepatol. 2009. PMID: 19743995 Review.
-
Fluid retention in cirrhosis: pathophysiology and management.QJM. 2008 Feb;101(2):71-85. doi: 10.1093/qjmed/hcm121. Epub 2008 Jan 9. QJM. 2008. PMID: 18184668 Review.
-
Ascites in cirrhosis: a review of management and complications.Neth J Med. 2007 Sep;65(8):283-8. Neth J Med. 2007. PMID: 17890787 Review.
-
Portal hypertension.Curr Opin Gastroenterol. 2006 May;22(3):254-62. doi: 10.1097/01.mog.0000218962.93806.9a. Curr Opin Gastroenterol. 2006. PMID: 16550040 Review.
-
Ascites: diagnosis and management.Med Clin North Am. 2009 Jul;93(4):801-17, vii. doi: 10.1016/j.mcna.2009.03.007. Med Clin North Am. 2009. PMID: 19577115 Review.
Cited by
-
Psychological stress induced zinc accumulation and up-regulation of ZIP14 and metallothionein in rat liver.BMC Gastroenterol. 2014 Feb 18;14:32. doi: 10.1186/1471-230X-14-32. BMC Gastroenterol. 2014. PMID: 24548602 Free PMC article.
-
Anti-fibro-hepatocarcinogenic Chinese herbal medicines: A mechanistic overview.J Intercult Ethnopharmacol. 2016 Jun 14;5(3):278-89. doi: 10.5455/jice.20160530032814. eCollection 2016 Jun-Aug. J Intercult Ethnopharmacol. 2016. PMID: 27366355 Free PMC article. Review.
-
Revision and update on clinical practice guideline for liver cirrhosis.Korean J Hepatol. 2012 Mar;18(1):1-21. doi: 10.3350/kjhep.2012.18.1.1. Epub 2012 Mar 22. Korean J Hepatol. 2012. PMID: 22511898 Free PMC article. No abstract available.
-
Paracentesis-induced acute kidney injury in decompensated cirrhosis - prevalence and predictors.Clin Exp Hepatol. 2019 Mar;5(1):55-59. doi: 10.5114/ceh.2019.83157. Epub 2019 Feb 20. Clin Exp Hepatol. 2019. PMID: 30915407 Free PMC article.
-
Management of Cirrhotic Ascites under the Add-on Administration of Tolvaptan.Int J Mol Sci. 2021 May 25;22(11):5582. doi: 10.3390/ijms22115582. Int J Mol Sci. 2021. PMID: 34070416 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical